Armonair Respiclick (fluticasone propionate MDPI) / Teva 
Welcome,         Profile    Billing    Logout  
 8 Diseases   0 Trials   0 Trials   40 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Armonair Respiclick (fluticasone propionate MDPI) / Teva
NCT06290102: Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

Completed
1
30
US
TEV-56248, - fluticasone propionate/albuterol sulfate multidose dry powder inhaler with e-module (Fp/ABS eMDPI), Fp MDPI, - fluticasone propionate multidose dry powder inhaler
Teva Branded Pharmaceutical Products R&D, Inc.
Asthma
10/24
10/24

Download Options